Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tacrolimus
Therapeutic Area : Urology
Study Phase : Phase II
Sponsor : Lipella Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement with Cook MyoSite
Details : The collaboration aims to facilitate Chemistry, Manufacturing, and Control documentation for Lipella's drug candidate LP-10 (liposomal tacrolimus), aimed at treating hemorrhagic cystitis. LP-10 has been granted Orphan Drug Designation by the FDA.
Brand Name : LP-10
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 17, 2023
Lead Product(s) : Tacrolimus
Therapeutic Area : Urology
Highest Development Status : Phase II
Sponsor : Lipella Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?